07:01:18 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2023-02-24 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-26 Kvartalsrapport 2022-Q2
2022-05-27 Kvartalsrapport 2022-Q1
2022-05-06 Ordinarie utdelning POLAR 0.00 SEK
2022-05-05 Årsstämma 2022
2022-02-25 Bokslutskommuniké 2021
2021-11-26 Kvartalsrapport 2021-Q3
2021-08-27 Kvartalsrapport 2021-Q2
2021-05-28 Kvartalsrapport 2021-Q1
2021-05-06 Ordinarie utdelning POLAR 0.00 SEK
2021-05-05 Årsstämma 2021
2021-02-26 Bokslutskommuniké 2020
2020-11-27 Kvartalsrapport 2020-Q3
2020-08-28 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning POLAR 0.00 SEK
2020-06-30 Årsstämma 2020
2020-05-29 Kvartalsrapport 2020-Q1
2020-02-28 Bokslutskommuniké 2019
2020-02-14 Extra Bolagsstämma 2020
2019-10-23 Kvartalsrapport 2019-Q3
2019-07-24 Kvartalsrapport 2019-Q2
2019-05-07 Split POLAR 16:1
2019-04-26 Kvartalsrapport 2019-Q1
2019-03-19 Årsstämma 2019
2019-02-04 Ordinarie utdelning POLAR 0.00 SEK
2019-02-01 Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Polarcool är verksamma inom medicinteknik. Idag är bolaget inriktade mot att produkter och lösningar inriktade för skador inom sport och aktivitet. Störst fokus återfinns inom forskning och utveckling av produkter som används vid behandling av hjärnskador vid exempelvis boxning, rugby och amerikansk fotboll. Verksamhet innehas på global nivå, med störst närvaro inom den europeiska marknaden.
2022-07-07 09:46:00

PolarCool AB (publ) has signed an agreement with the Bundesliga club TSG Hoffenheim for use of the PolarCap® System. The agreement marks an important first step for the company in the German football market.

PolarCool develops the product PolarCap® System which alleviates the effects of concussion. The company's primary customers are clubs and organizations in sports such as ice hockey, rugby, handball, and sports with an increased risk of concussion. The company has recently landed several strategic agreements in France and the United Kingdom, while the company has also continued to broaden its presence in the domestic market.

TSG Hoffenheim compete in the Bundesliga which is recognized worldwide as Germanies highest league. The team will use the PolarCap® from the beginning of the upcoming season in an initial evaluation period, with the possibility of continuing into a two-year commercial agreement after the evaluation. The agreement is limited in size but marks an important breakthrough in the German football market.

In addition to the ice hockey and rugby markets where head injuries are very common, the football market is also very interesting for PolarCool due to its market size. Even though head injuries are not as frequent in football, the injury creates major problems and significant costs to clubs when they occur. Because of this, PolarCool is facing increased interest from several top European clubs.

PolarCool's CEO Erik Andersson comments:

- The agreement with the German top club TSG Hoffenheim is very gratifying. The German football market, along with France and the United Kingdom, are very interesting markets for PolarCool in Europe. We have previously had breakthroughs in the top football leagues in both France and England. It has increased the interest from other clubs in the markets significantly. Our hope is to now be able to reach out to more German clubs as well as other clubs on the European football market.

PolarCool has targeted Germany as a market of importance and the agreement with TSG Hoffenheim will aid in the company's market approach. Recently within Germany the company announced the agreement renewal of DEL Ice Hockey team Adler Mannhiem, who have extended their PolarCap® agreement to 2024.